Boston Partners Vivos Therapeutics, Inc. Transaction History

Boston Partners

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	SELL	$0.83 - $21.25 $37,921 - $970,870	-45,688 Reduced 36.8%	78,454 $51,000
Q2 2022 Aug 10, 2022	SELL	$1.12 - $2.18 $14,797 - $28,802	-13,212 Reduced 9.62%	124,142 $160,000
Q1 2022 May 10, 2022	BUY	$1.63 - $3.63 $47,822 - $106,500	29,339 Added 27.16%	137,354 $368,000
Q4 2021 Feb 04, 2022	BUY	$2.25 - $4.11 $138,069 - $252,206	61,364 Added 131.54%	108,015 $243,000
Q3 2021 Nov 05, 2021	BUY	$2.71 - $5.9 $126,424 - $275,240	46,651 New	46,651 $188,000

Ticker VVOS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 23,012,100
Market Cap $78.2M
Description
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dent...

Get notified when there are updates to the investment portfolio of Boston Partners, based on Form 13F filings with the SEC.

Stay updated on Boston Partners with notifications on news.